Collegium Pharmaceutical Inc reports results for the quarter ended in December - Earnings Summary

Collegium Pharmaceutical

24/02/2022 23:19

* Collegium Pharmaceutical Inc  COLL.OQ  reported a
quarterly
adjusted loss of 51 cents​​ per share for the quarter ended in
December. The mean expectation of seven analysts for the quarter
was for earnings of $1.04 per share.
    * Revenue fell 64.1% to $27.36 million from a year ago; 
analysts
expected $81.61 million. 
    * Collegium Pharmaceutical Inc's reported EPS for the
quarter was
a loss of 73 cents​.
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Collegium Pharmaceutical Inc shares had risen by 20.4%
this
quarter.
    * The company reported a quarterly loss of $25.03 million.
    * Wall Street's median 12-month price target for Collegium
Pharmaceutical Inc is $27.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated February 24 at 11:19 p.m.
 ​All figures in US dollars unless otherwise stated